(RxWiki News) The US Food and Drug Administration (FDA) has approved the first injectable medication for cellulite.
This medication is called Qwo (collagenase clostridium histolyticum-aaes). The FDA approved it to treat adult women with moderate to severe cellulite in the buttocks.
Qwo comes in the form of an injection and is given under the skin (subcutaneously) of each buttock by your health care provider.
You may receive up to 12 injections per treatment area. Each treatment visit may include up to two treatment areas.
These injections will be given 21 days apart for three treatment visits.
Common side effects of Qwo may include hardness, bruising, discoloration, itching, pain, redness, swelling and warmth in the area being treated.
Tell your health care provider before receiving this injection if you have a bleeding problem or if you take blood thinners or similar medications. This medication must be used with caution in those with bleeding abnormalities or those who take antiplatelet or anticoagulant medication.
People can expect this injection to be available in Spring 2021. Approval was granted to Endo International plc.